DOXGX | TQVAX | DOXGX / TQVAX | |
Total Expense Ratio | 0.41 | 0.99 | 41% |
Annual Report Gross Expense Ratio | 0.46 | 2.33 | 20% |
Fund Existence | 3 years | 9 years | - |
Gain YTD | 3.684 | 1.617 | 228% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 114B | 65.2M | 174,847% |
Annual Yield % from dividends | 1.49 | 1.11 | 134% |
Returns for 1 year | 6.03 | 2.44 | 247% |
Returns for 3 years | 28.44 | 18.60 | 153% |
Returns for 5 years | N/A | 62.96 | - |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IBDS | 24.14 | -0.01 | -0.04% |
iShares iBonds Dec 2027 Term Corp ETF | |||
UJAN | 39.60 | -0.22 | -0.54% |
Innovator US Equity Ultra Buff ETF™ Jan | |||
JAJL | 27.66 | -0.18 | -0.65% |
Innovator Eq Dfnd Prot ETF - 6Mo Jan/Jul | |||
SWZ | 6.26 | -0.11 | -1.73% |
Total Return Securities Inc | |||
FFSM | 26.23 | -0.48 | -1.80% |
Fidelity Fundamental Small-Mid Cap ETF |